Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-ro autoantibodies

Journal of Pediatrics

Volumn 142, Issue 6, 2003, Pages 678-683

  Cimaz, Rolando ^a   Spence, Dawn L ^b   Hornberger, Lisa ^b   Silverman, Earl D ^b  

^a ICP   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LA ANTIBODY; LIVER ENZYME; RO ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BIRTH; BLOOD DISEASE; CANADA; CLINICAL FEATURE; CONGENITAL HEART BLOCK; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENZYME ANALYSIS; FEMALE; HUMAN; INCIDENCE; INFANT; ITALY; LABORATORY TEST; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MOTHER; PATIENT REFERRAL; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH;

EID: 0038132924     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.233     Document Type: Article

References (31)

1. Buyon JP. Neonatal lupus. Curr Opin Rheumatol 1996;8:485-90.
2. Brucato A, Buyon JP, Horsfall AC, Lee LA, Reichlin M. Fourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB System. Clin Exp Rheumatol 1999; 17:130-6.
3. Cimaz R, Catelli L, Luzzana C, Panzeri P, Meroni PL. Neonatal lupus syndromes. Isr Med Assoc J 2000;2:228-31.
4. Lee L. Neonatal lupus: clinical features, therapy, and pathogenesis. Curr Rheum Rep 2001;3:391-5.
5. Silverman ED, Buyon JP, Laxer RM, Hamilton R, Bini P, Chu JL, et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995;100:499-505.
6. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
7. Laxer RM, Roberts EA, Gross KR, Britton JR, Cutz E, Dimmick J, et al. Liver disease in neonatal lupus erythematosus. J Pediatr 1990;116:238-48.
8. Lee LA, Reichlin M, Ruyle SZ, Weston WL. Neonatal lupus liver disease. Lupus 1993;5:333-8.
9. Selander B, Cedergren S, Domanski H. A case of severe neonatal lupus erythematosus without cardiac or cutaneous involvement. Acta Pediatr 1998;87:105-7.
10. Watson R, Kang JE, May M, Hudak M, Kickler T, Provost TT. Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol 1988;124:560-3.
11. Wolach B, Choc L, Pomeranz A, Ben Ari Y, Douer D, Metzker A. Aplastic anemia in neonatal lupus erythematosus. Am J Dis Child 1993;147:941-4.
12. Thornton CM, Eichenfield LF, Shinall EA, Siegfried E, Rabinowitz LG, Esterly NB, et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol 1995;33:19-25.
13. Lee LA, Weston WL. Cutaneous lupus erythematosus during the neonatal and childhood periods. Lupus 1997;6:132-8.
14. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002;109. Available at: http://www.pediatrics.org/cgi/content/full/109/1/e11.
15. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital heart block in newborns of mothers with antiRo/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
16. Lockshin MD, Bonfa E, Elkon K, Druzin ML. Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum 1988;31:697-701.
17. Ramsey-Goldman R, Hom D, Deng JS, Ziegler GC, Kahl LE, Steen VD, et al. Anti-SS-A antibodies and fetal outcome in maternal systemic lupus eryrhematosus. Arthritis Rheum 1986;29:1269-73.
18. Fu LS, Hwang B, Lee BH. Newborns of Chinese mother with systemic lupus erythematosus (SLE). Acta Paediatr Sin 1992;33:341-9.
19. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.
20. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996;100:328-32.
21. Julkunen H, Kaaja R, Siren MK, Mack C, McCready S, Holthhofer H, et al. Immune-mediated congenital heart block (CHB): identifiyng and counseling patients at risk for having children with CHB. Semin Arthritis Rheum 1998;28:97-106.
22. Cimaz R, Airoldi ML, Careddu P, Centinaio G, Catelli L, Franceschini F, et al. Transient neonatal bradycardia without heart block associated with anti-Ro antibodies. Lupus 1997;6:487-8.
23. Brucato A, Cimaz R, Catelli L, Meroni P. Anti-Ro-associated sinus bradycardia in newborns [letter]. Circulation 2000; 102:E88-9. Available at: http://circ.ahajournals.org/cgi/content/full/102/11/e88.
24. Menon A, Silverman ED, Gow RM, Hamilton RM. Chronotropic competence of the sinus node in congenital complete heart block. Am J Cardiol 1998;82:1119-21.
25. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000;43:1049-53.
26. Gordon PA, Khamashta MA, Hughes GRV, Rosenthal E. Increase in heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al. Arthritis Rheum 2001;44:242-3.
27. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-14.
28. Kanagasegar S, Cimaz R, Kurien BT, Brucato A, Scofield RH.. Neonatal lupus manifests as isolated neutropenia and mildly abnormal liver functions. J Rheumatol 2002;29:187-91.
29. Rader MD, O'Brien C, Liu YS, HarleyJB, Reichlin M. Heterogeneity of the Ro/SSA antigen: different molecular forms in lymphocytes and red blood cells. J Clin Invest 1989;83:1293-8.
30. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000;137:674-80.
31. Weston WL, Morelli JG, Lee LA. The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. J Am Acad Dermatol 1999;40:675-81.